Medication info

Nessina Act Tablet 25/15 mg

Prescription medicationTabletApproval withdrawn
Ingredient · strength
Alogliptin Benzoate›34mg / 1 tabletPioglitazone Hydrochloride›16.53mg / 1 tablet
Manufacturer / importer
Celltrion Pharm, Inc.
Appearance
Yellow, biconvex, round film-coated tablets
Packaging
28 tablets (7 tablets/PTP x 4), 100 tablets (10 tablets/PTP x 10)
Approval status
Approval withdrawn

MFDS item code 201404896 · Approved 2014.10.24

This product's status changed to Approval withdrawn on 2024.10.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
This medicine is administered once daily, with or without food. Do not split the tablets. For patients with no prior history of antidiabetic drug treatment who do not achieve adequate glycemic control with monotherapy: Administer this medicine 25mg/15mg. For patients who do not achieve adequate glycemic control with metformin monotherapy: Administer this medicine 25mg/15mg. For patients who do not achieve adequate glycemic control with pioglitazone monotherapy: Administer this medicine 25mg/15mg or 25mg/30mg, depending on the current treatment regimen. For patients who do not achieve adequate glycemic control with combination therapy of pioglitazone and metformin: Administer this medicine 25mg/15mg or 25mg/30mg, depending on the current treatment regimen. Replacement of combination therapy with alogliptin and pioglitazone: When switching from combination therapy with alogliptin and pioglitazone to this medicine, start at the current doses of alogliptin and pioglitazone. This medicine may be increased to a maximum of 25mg/30mg once daily according to the glycemic response. Patients with mild renal impairment (creatinine clearance ≥50 mL/min): No dose adjustment is required. Patients with moderate renal impairment (creatinine clearance ≥30~ <50 mL/min): Administer this medicine 12.5 mg/15 mg or 12.5 mg/30 mg once daily. This medicine should not be administered to patients with severe renal impairment or end-stage renal disease. Because dose adjustment may be necessary depending on renal function, assessment of renal function is recommended before starting treatment with this medicine and periodically thereafter.

Ingredients

Importer
Celltrion Pharm, Inc.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes. Alogliptin and pioglitazone work together to effectively improve blood glucose levels when used in conjunction with diet and exercise therapy. Therefore, this medication can assist in the treatment of individuals who have difficulty managing their blood sugar.

Dosage and Administration

Adult dosage

This medicine is administered once daily, with or without food. Do not split the tablets. For patients with no prior history of antidiabetic drug treatment who do not achieve adequate glycemic control with monotherapy: Administer this medicine 25mg/15mg. For patients who do not achieve adequate glycemic control with metformin monotherapy: Administer this medicine 25mg/15mg. For patients who do not achieve adequate glycemic control with pioglitazone monotherapy: Administer this medicine 25mg/15mg or 25mg/30mg, depending on the current treatment regimen. For patients who do not achieve adequate glycemic control with combination therapy of pioglitazone and metformin: Administer this medicine 25mg/15mg or 25mg/30mg, depending on the current treatment regimen. Replacement of combination therapy with alogliptin and pioglitazone: When switching from combination therapy with alogliptin and pioglitazone to this medicine, start at the current doses of alogliptin and pioglitazone. This medicine may be increased to a maximum of 25mg/30mg once daily according to the glycemic response. Patients with mild renal impairment (creatinine clearance ≥50 mL/min): No dose adjustment is required. Patients with moderate renal impairment (creatinine clearance ≥30~ <50 mL/min): Administer this medicine 12.5 mg/15 mg or 12.5 mg/30 mg once daily. This medicine should not be administered to patients with severe renal impairment or end-stage renal disease. Because dose adjustment may be necessary depending on renal function, assessment of renal function is recommended before starting treatment with this medicine and periodically thereafter.

Precautions

This medication may cause or worsen congestive heart failure in some patients with swelling or weakness of the heart. After starting treatment or increasing the dosage, carefully monitor for symptoms of heart failure such as sudden weight gain, shortness of breath, and swelling. If these symptoms occur, consult a healthcare professional immediately for appropriate treatment, and discontinue or reduce the dosage of this medication if necessary. Patients with heart failure or a history of heart failure should not use this medication. This medication may exacerbate heart failure by causing fluid retention, so patients with edema or heart issues should exercise particular caution. Additionally, this medication may increase the risk of bladder cancer, so inform a physician immediately if there is a history of bladder cancer or any abnormal symptoms in the bladder. Patients experiencing diabetic ketoacidosis, coma, severe infections, pre- and post-surgical patients, those with liver impairment or severe kidney impairment, pregnant women or women who may become pregnant, and those with hypersensitivity to this medication should not use it. This medication may cause ovulation in premenopausal women, increasing the risk of pregnancy, so appropriate contraception should be used. During treatment, be alert for symptoms of hypoglycemia, especially when taken with other blood sugar-lowering agents like insulin or sulfonylureas as the risk of hypoglycemia may be higher. If sudden severe joint pain, skin blisters, rashes, etc., occur while using this medication, consult a physician immediately. It is safe to avoid using this medication for pregnant or breastfeeding women. Elderly patients or those with impaired kidney function or poor nutritional status should use this medication with caution. This medication may interact with other drugs, so be sure to inform healthcare providers of any other medications being taken. Finally, this medication should be stored out of reach of children, in its original container.

Side effects

Congestive heart failure, excessive and rapid weight change, shortness of breath, edema, fluid retention, hypoglycemia, nasopharyngitis, low back pain, upper respiratory infection, influenza, headache, sinusitis, myalgia, pharyngitis, pancreatitis, hypersensitivity reaction, serum sickness, decreased hemoglobin, elevated serum creatine kinase, decreased vision, diabetic macular edema, liver failure, weight gain, edema, abnormal liver function, bladder cancer, fracture, macular edema, severe joint pain with disability, vesicular pemphigus, anaphylaxis, angioedema, rash, urticaria, Stevens-Johnson syndrome, pemphigus, angioedema, elevated serum ALT, elevated serum AST, acute pancreatitis, diarrhea, gastric ulcer, exacerbation of gastritis, hemorrhagic gastric ulcer, appendicitis, abscess, infection, wound defect, chest discomfort, generalized edema, systemic weakness, cirrhosis, cholelithiasis, acute renal failure, nephrolithiasis, impaired renal function, myocardial infarction, angina, anorexia, cerebral infarction, transient ischemic attack, laceration, worsening of atrial fibrillation, speech disorder, pruritus, hematuria, conjunctivitis, glaucoma, macular degeneration, cataract, keratitis, retinal disease, retinal disorder, retinal disease, cholelithiasis, unspecified abnormal liver function tests, cirrhosis, biliary sclerosis, fatty liver, elevated AST, elevated ALT, shingles, depression, hypersensitivity, erectile dysfunction, insomnia, sleep disorder, prostatic hyperplasia, benign prostatic hyperplasia, orthostatic hypotension, hypotension, tinnitus, acute hearing loss, Meniere's disease, coronary occlusion, exacerbation of angina, bradycardia, palpitations, hypertension, contusion, tendon rupture, chest burning, constipation, gastric and intestinal air retention, gastritis, hemorrhoids, indigestion, cough, increased sputum, bronchospasm, dry cough, chronic obstructive pulmonary disease, throat irritation, tonsillitis, worsening of pneumonia, worsening of shortness of breath, chest pain, low back pain, hyperglycemia, hyperlipidemia, diabetes complications, dyslipidemia, increased triglycerides, increased blood sugar levels, dizziness, vertigo, cerebral dysfunction, joint pain, neck/shoulder pain, arthritis, weakness of legs, malaise, trigger finger, plantar fasciitis, vertebral fracture, rhabdomyolysis, pruritus, contact dermatitis, nail disease, otitis externa, roseola, rosacea, contact dermatitis, furunculosis, seborrheic dermatitis, cystitis, exacerbation of cystitis, increased frequency of urination, neurogenic bladder, renal cyst, urethritis, increased serum creatinine, diabetic retinopathy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, preferably at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication for a longer duration.

Appearance and packaging

Appearance

Yellow, biconvex, round film-coated tablets

Package unit

28 tablets (7 tablets/PTP x 4), 100 tablets (10 tablets/PTP x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.